These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22205200)

  • 1. The epigenetic code in depression: implications for treatment.
    Schroeder M; Hillemacher T; Bleich S; Frieling H
    Clin Pharmacol Ther; 2012 Feb; 91(2):310-4. PubMed ID: 22205200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetic mechanism of major depression].
    Morinobu S
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1101-12. PubMed ID: 24450142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and depression: current challenges and new therapeutic options.
    Schroeder M; Krebs MO; Bleich S; Frieling H
    Curr Opin Psychiatry; 2010 Nov; 23(6):588-92. PubMed ID: 20644477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Modifications of Major Depressive Disorder.
    Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 6. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
    Deussing JM; Jakovcevski M
    Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic therapies reach main street.
    Bates SE
    Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the potential of epigenetics in drug development?
    Lundstrom K
    Future Med Chem; 2015; 7(3):239-42. PubMed ID: 25826357
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
    Terui Y
    Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cancer drugs based on epigenetics, miRNAs and their interactions.
    Roukos DH
    Epigenomics; 2011 Dec; 3(6):675-8. PubMed ID: 22126285
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic agents in combined anticancer therapy.
    Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
    Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of histone deacetylase inhibitors for bladder cancer treatment.
    Tanji N; Ozawa A; Kikugawa T; Miura N; Sasaki T; Azuma K; Yokoyama M
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):959-65. PubMed ID: 21707293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
    Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
    Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
    Lunke S; El-Osta A
    J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.